文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

裂红细胞检测对脓毒症患者死亡率和器官衰竭的影响

THE IMPACT OF SCHISTOCYTE DETECTION ON MORTALITY AND ORGAN FAILURE IN PATIENTS WITH SEPSIS.
PubMed 文献 · Shock · 2024-08-12
一句话结论脓毒症患者中检出裂红细胞与90天和1年死亡率升高及器官衰竭加重相关,可能提示疾病严重程度。

本研究为日本滋贺医科大学医院2015年1月至2021年4月的回顾性观察研究,纳入330例脓毒症或脓毒性休克患者,通过每日血液学检查识别裂红细胞。41例(12.4%)检出裂红细胞,其90天和1年死亡率分别为48.7%和68.2%,显著高于未检出者(P<0.001)。检出裂红细胞者序贯器官衰竭评估(SOFA)评分更高,尤其是凝血和肾脏分量,且调整年龄、性别和基线合并症后结果仍持续。作者认为裂红细胞检测可能为脓毒症严重程度提供重要信息,指导靶向治疗策略,并可能改善长期结局。

要点

  • 脓毒症患者中裂红细胞检出率为41/330(12.4%),检出者90天死亡率48.7%、1年死亡率68.2%,均显著升高(P<0.001)。
  • 检出裂红细胞者SOFA评分更高,尤其凝血和肾脏分量,提示器官衰竭更严重。
  • 调整年龄、性别和基线合并症后,裂红细胞与长期死亡率和器官衰竭的关联持续存在。
  • 检出裂红细胞者需要频繁输注红细胞,进一步提示病情严重。
  • 每日血液学检查识别裂红细胞可能为脓毒症严重程度评估和靶向治疗提供线索。

适用人群与场景

  • 日本滋贺医科大学医院2015年1月至2021年4月诊断为脓毒症或脓毒性休克的患者,共330例。

诊断标准与关键阈值

  • 通过每日血液学检查识别裂红细胞。

研究设计与关键结果

  • 回顾性观察研究,纳入330例脓毒症或脓毒性休克患者,41例检出裂红细胞。
  • 检出裂红细胞者90天死亡率为48.7%,1年死亡率为68.2%,均显著高于未检出者(P<0.001)。
  • 检出裂红细胞者SOFA评分更高,尤其凝血和肾脏分量,提示器官衰竭更严重。
  • 调整年龄、性别和基线合并症等混杂因素后,上述关联持续存在。
  • 检出裂红细胞者需要频繁输注红细胞。

证据类型、等级与局限

  • 证据类型:回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,裂红细胞检测可能为脓毒症疾病严重程度提供重要信息,指导靶向治疗策略,并可能改善脓毒症管理的长期结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Purpose : This study aimed to investigate the presence of schistocytes in patients with sepsis and its association with mortality and organ failure. Methods : We conducted a retrospective observational study at Shiga University of Medical Science Hospital, Japan, from January 2015 to April 2021. This study included patients diagnosed with sepsis or septic shock. Schistocytes were identified through daily hematological examinations. Moreover, data on mortality rates and organ failure based on Sequential Organ Failure Assessment scores were systematically collected and analyzed. Results : Schistocytes were detected in 41 of the 330 patients with sepsis. The presence of schistocytes was associated with significantly high 90-day and 1-year mortality rates (48.7% and 68.2%, respectively; P < 0.001). Patients with schistocytes exhibited higher Sequential Organ Failure Assessment scores, particularly in the coagulation and renal components, indicating more severe organ failure than that observed in patients without schistocytes. These findings persisted even after adjusting for confounding factors, such as age, sex, and baseline comorbidities. Additionally, we observed that patients with schistocytes required frequent red blood cells, further highlighting the severity of their conditions. Conclusion : Schistocytes are significantly associated with increased long-term mortality and organ failure in patients with sepsis. Their detection may provide crucial insights into disease severity, guide targeted therapeutic strategies, and potentially improve the long-term outcomes of sepsis management.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Tanaka T, Fujino K, Tsujita Y, et al. THE IMPACT OF SCHISTOCYTE DETECTION ON MORTALITY AND ORGAN FAILURE IN PATIENTS WITH SEPSIS. Shock. 2024. PMID: 39158562. doi:10.1097/SHK.0000000000002440

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。